Recent Updates
Recently added Catalysts
OMER Positive Sentiment

Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026

Monday, August 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Omeros Corporation will release its financial results for Q2 2026 on August 12, 2026, after market close. The company will also host a conference call and webcast at 4:30 p.m. ET to discuss the results and recent developments. This event highlights Omeros' commitment to keeping stakeholders informed.

Market Sentiment Analysis

POSITIVE FACTORS

  • Omeros Corporation is preparing to announce its financial results.
  • The company is engaging with investors through a conference call.
  • The announcement indicates ongoing business activity and transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+449%
120-day peak, hindsight
Typical move
13.7%
average across 2 past catalysts
Cash runway
~25 mo
Minimal dilution risk
Lead asset
OMS103HP
Phase 3 · Anterior Cruciate Ligament Reconstruction

Full Press Release Details

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the second quarter of 2026 on Wednesday, August 12, 2026 after market close. Omeros management will host a conference call and webcast that same day at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss recent developments and highlights as well as the Company’s financial results. Conference Call Details and Webcast Link Instructions To access the live webcast, please

Frequently Asked Questions

When will Omeros announce its Q2 2026 financial results?

Omeros will announce its Q2 2026 financial results on August 12, 2026.

What time is the Omeros conference call scheduled?

The conference call is scheduled for 4:30 p.m. Eastern Time.

How can I access the Omeros webcast?

Details for accessing the live webcast will be provided in the announcement.

ShareAdd on Google
Tags: OMER Viatris Investor Conferences Healthcare Omeros Corporation financial results Q2 2026 conference call NASDAQ: OMER
Last updated: Aug 10, 2026

Biotech snapshot

Cash runway
$135M liquidity · $5M/mo burn
~25 mo
Minimal dilution risk
Lead asset
OMS103HPPhase 3
Anterior Cruciate Ligament Reconstruction →

Catalyst track record

+449%
best trade around OMER's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for OMER.

See every catalyst's timing & PoA →